Emmessar Biotech And Nutrition (BOM:524768) Total Liabilities: ₹14.15 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524768 Emmessar Biotech And Nutrition Ltd BOM:524768
55 GF Score
Price ₹25.34
GF Value ₹18.67
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Emmessar Biotech And Nutrition Total Liabilities?

Emmessar Biotech And Nutrition BOM:524768 +1.93% 55 Total Liabilities is ₹14.15 Mil as of Mar. 2026. GuruFocus rates BOM:524768 with a GF Score™ of 55/100 and a GF Value™ of ₹18.67 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Emmessar Biotech And Nutrition's Total Liabilities for the quarter that ended in Mar. 2026 was ₹14.15 Mil.

Emmessar Biotech And Nutrition's quarterly Total Liabilities declined from Sep. 2025 (₹15.23 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹14.15 Mil).

Emmessar Biotech And Nutrition's annual Total Liabilities increased from Mar. 2024 (₹13.41 Mil) to Mar. 2025 (₹15.12 Mil) but then declined from Mar. 2025 (₹15.12 Mil) to Mar. 2026 (₹14.15 Mil).

Emmessar Biotech And Nutrition Total Liabilities Historical Data

* Premium members only.

The historical data trend for Emmessar Biotech And Nutrition's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emmessar Biotech And Nutrition Total Liabilities Chart

Emmessar Biotech And Nutrition Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.45 12.78 13.41 15.12 14.15

Emmessar Biotech And Nutrition Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.12 0.00 15.23 0.00 14.15
BOM:524768
55GF Score
Emmessar Biotech And Nutrition Ltd BOM:524768
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Emmessar Biotech And Nutrition Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Emmessar Biotech And Nutrition's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.852+(0+10.301
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=14.15

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=95.301-81.148
=14.15

Emmessar Biotech And Nutrition's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.852+(0+10.301
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=14.15

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=95.301-81.148
=14.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹14.15 Mil mean?
Emmessar Biotech And Nutrition (BOM:524768) has a Total Liabilities of ₹14.15 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Emmessar Biotech And Nutrition and its competitors.
Is Emmessar Biotech And Nutrition's Total Liabilities too high?
Emmessar Biotech And Nutrition's current Total Liabilities is ₹14.15 Mil. Overall, Emmessar Biotech And Nutrition has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Emmessar Biotech And Nutrition's Total Liabilities compare to ZTS?
Emmessar Biotech And Nutrition's Total Liabilities of ₹14.15 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Emmessar Biotech And Nutrition and its competitors. Emmessar Biotech And Nutrition's current Total Liabilities is ₹14.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emmessar Biotech And Nutrition stock overvalued right now?
Based on GuruFocus' analysis, Emmessar Biotech And Nutrition (BOM:524768) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹18.67, compared to a current price of ₹25.34 — trading 35.7% above its estimated fair value. The current Total Liabilities is ₹14.15 Mil. Emmessar Biotech And Nutrition's overall GF Score™ is 55/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Emmessar Biotech And Nutrition (BOM:524768), the current Total Liabilities is ₹14.15 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Emmessar Biotech And Nutrition (BOM:524768) Overvalued in 2026?

Based on GuruFocus' analysis, Emmessar Biotech And Nutrition stock appears to be overvalued. The current stock price of ₹25.34 is trading 35.7% above its estimated GF Value™ of ₹18.67. GuruFocus considers Emmessar Biotech And Nutrition to be Significantly Overvalued.

Key valuation signals for BOM:524768:

  • Total Liabilities: ₹14.15 Mil
  • GF Value™: ₹18.67 vs. price of ₹25.34 (35.7% above fair value)
  • GF Score™: 55/100 with 1 warning sign

No single metric tells the full story. See the BOM:524768 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Emmessar Biotech And Nutrition Business Description

Address 38, Cawasji Patel Street, 29, Kamer Building, 4th floor, Fort, Mumbai, MH, IND, 400001
Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.
55GF Score

Get the complete analysis for BOM:524768

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.34
Price
₹18.67
GF Value